Cargando…
Glioblastomas with copy number gains in EGFR and RNF139 show increased expressions of carbonic anhydrase genes transformed by ENO1
BACKGROUND: Prominence of glycolysis in glioblastomas may be non-specific or a feature of oncogene-related subgroups (i.e. amplified EGFR, etc.). Relationships between amplified oncogenes and expressions of metabolic genes associated with glycolysis, directly or indirectly via pH, were therefore inv...
Autores principales: | Beckner, Marie E., Pollack, Ian F., Nordberg, Mary L., Hamilton, Ronald L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802406/ https://www.ncbi.nlm.nih.gov/pubmed/27051584 http://dx.doi.org/10.1016/j.bbacli.2015.11.001 |
Ejemplares similares
-
A Novel RNF139 Mutation in Hemangioblastomas: Case Report
por: Yang, Ping, et al.
Publicado: (2019) -
EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Sesboüé, R, et al.
Publicado: (2012) -
Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Ålgars, A, et al.
Publicado: (2012) -
Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma
por: Muñoz-Hidalgo, Lisandra, et al.
Publicado: (2019) -
Absence of copy number gain of EGFR: A possible predictive marker of long‐term response to afatinib
por: Nakamura, Tomomi, et al.
Publicado: (2022)